Nuveen
RXO icon

Nuveen’s RXO RXO Stock Holding History

Nuveen’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14M Buy
508,274
+26,006
+5% +$574K ﹤0.01% 1481
2026
Q1 		$7.05M Buy
482,268
+3,241
+0.7% +$47.6K ﹤0.01% 1737
2025
Q4 		$6.05M Sell
479,027
-561,701
-54% -$8.29M ﹤0.01% 1824
2025
Q3 		$16M Sell
1,040,728
-5,199
-0.5% -$83.8K ﹤0.01% 1274
2025
Q2 		$16.4M Buy
1,045,927
+621,460
+146% +$9.42M ﹤0.01% 1221
2025
Q1 		$8.11M Sell
424,467
-194,822
-31% -$4.26M ﹤0.01% 1675
2024
Q4 		$14.8M Sell
619,289
-16,568
-3% -$462K ﹤0.01% 1361
2024
Q3 		$17.8M Buy
635,857
+61,025
+11% +$1.72M 0.01% 1268
2024
Q2 		$15M Sell
574,832
-10,323
-2% -$215K ﹤0.01% 1323
2024
Q1 		$12.8M Sell
585,155
-174,421
-23% -$3.74M ﹤0.01% 1458
2023
Q4 		$17.7M Sell
759,576
-126,530
-14% -$2.55M 0.01% 1237
2023
Q3 		$17.5M Sell
886,106
-142,377
-14% -$2.8M 0.01% 1114
2023
Q2 		$23.3M Buy
1,028,483
+383,441
+59% +$7.72M 0.01% 985
2023
Q1 		$12.7M Buy
645,042
+74,336
+13% +$1.43M ﹤0.01% 1335
2022
Q4 		$9.82M Buy
+570,706
New +$10.1M ﹤0.01% 1506

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Nuveen's RXO Position: Q2 2026 in Review

Nuveen increased its RXO (RXO) stake by 5.4% in Q2 2026, buying an estimated $574K and bringing the position to 508,274 shares worth $14M. The position accounts for ﹤0.01% of the portfolio, ranked #1481.

Nuveen first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $23.3M in Q2 2023. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Nuveen held 508,274 shares of RXO worth $14M as of Q2 2026.
  • Nuveen bought 26,006 RXO shares in Q2 2026, an estimated $574K.
  • RXO made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1481 holding.
  • Nuveen first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • Nuveen's RXO position peaked at $23.3M in Q2 2023.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.